logo

For the Inventor, By the Inventor

Radnor, PA, United States of America

Marinus Pharmaceuticals

USPTO Granted Patents = 24



Trademarks = 5

Forward Citations = 262

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Kenneth Shaw (12 out of 52 patents)

silverMedal Mingbao Zhang (12 out of 25 patents)

bronzeMedal Alex Aimetti (8 out of 10 patents)

4.  David Czekai (7 out of 7 patents)

5.  Joseph Hulihan (7 out of 9 patents)

6.  Christopher Cashman (4 out of 4 patents)

7.  Lorianne Masuoka (4 out of 4 patents)

8.  Jaakko Lappalainen (4 out of 4 patents)

9.  Scott Braunstein (4 out of 6 patents)

10.  Maciej Gasior (3 out of 3 patents)

11.  Julia Tsai (3 out of 3 patents)

12.  Raymond C Glowaky (1 out of 7 patents)

13.  Alan J Hutchison (1 out of 128 patents)


24 patents:

1. 12268696 - Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders (2025-04-08),
2. 12246026 - Ganaxolone for use in treatment of status epilepticus (2025-03-11),
3. 12115169 - Ganaxolone for use in treating tuberous sclerosis complex and seizure disorders (2024-10-15),
4. 11980625 - Ganaxolone for use in treating tuberous sclerosis complex (2024-05-14),
5. 11701367 - Ganaxolone for use in treating tuberous sclerosis complex (2023-07-18),
6. 11679117 - Ganaxolone for use in treatment of status epilepticus (2023-06-20),
7. 11266662 - Ganaxolone for use in prophylaxis and treatment of postpartum depression (2022-03-08),
8. 11110100 - Ganaxolone for use in treatment of status epilepticus (2021-09-07),
9. 11071740 - Method of treatment using nanoparticulate ganaxolone formulations (2021-07-27),
10. 11000531 - Methods of treating certain depressive disorders and delirium tremens (2021-05-11),
11. 10780099 - Injectable neurosteroid formulations containing nanoparticles (2020-09-22),
12. 10639317 - Methods of treating certain depressive disorders and delirium tremens (2020-05-05),
13. 10391105 - Methods of treating certain depressive disorders and delirium tremens (2019-08-27),
14. 9452176 - Solid ganaxolone compositions and methods for the making and use thereof (2016-09-27),
15. 9056116 - Liquid ganaxolone formulations and methods for the making and use thereof (2015-06-16),
Company Overview
Marinus Pharmaceuticals is a biopharmaceutical company based in Radnor, Pennsylvania, focused on developing innovative therapies for patients with epilepsy and other central nervous system disorders. The company specializes in advancing its proprietary drug candidates aimed at addressing unmet medical needs in the treatment of rare and complex neurological conditions. Through rigorous research and development, Marinus aims to improve the quality of life for individuals affected by these challenging disorders.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

24 Patents

#2 in Radnor, PA

#512 in Pennsylvania

#13,895 in US

#26,686 in the World

Radnor, PA (US)
Radnor, PA, United States of America

Marinus Pharmaceuticals

Forward Citations = 262

13 inventors:

goldMedal Kenneth Shaw (12 out of 52 patents)

silverMedal Mingbao Zhang (12 out of 25 patents)

bronzeMedal Alex Aimetti (8 out of 10 patents)

4.  David Czekai (7 out of 7 patents)

5.  Joseph Hulihan (7 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Marinus Pharmaceuticals. Retrieved from https://idiyas.com/company/marinus-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…